Stocks
ChemoCentryx (CCXI) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 6 846% | 7 486% | 8 896% | 505.4% | 436.3% | 1 290% | |||
| Changes by years, y/y, % | -5 636pp | +641pp | +1 409pp | -8 390pp | -69pp | -48.9% | |||
ChemoCentryx. R&D/CAPEX, %
ChemoCentryx. R&D/CAPEX, changes, pp
ChemoCentryx (CCXI) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| R&D/CAPEX, % | 632.5% | 458.6% | 3 808% | 7 802% | 3 553% | 1 290% | ||
| Changes by years, y/y, % | -854pp | -5pp | +3 579pp | +7 587pp | +2 921pp | |||
| Changes by quarters, q/q, % | +417pp | -174pp | +3 349pp | +3 994pp | -4 249pp | |||
